30-May-2026
Download PDF
Titan Bio-Tech
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors at its meeting held today i.e. Saturday 30th May 2026 Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March 2026 Recommendation of Dividend re appointment of Cost Auditor and Appointment of Scrutinizer
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
